“The compound SR-17018 is the primary biased agonist on the mu opioid receptor that does not lead to tolerance with chronic use,” suggests Stahl, a senior staff members scientist while in the Bohn lab. “It is a desirable characteristic for prospective use within the context of Serious, critical soreness.” HealingEnergy14 stated: Amon